LEADER 00850nam0-22003011i-450-
001 990000682400403321
005 20080304145931.0
035   $a000068240
035   $aFED01000068240
035   $a(Aleph)000068240FED01
035   $a000068240
100   $a20020821d1985----km-y0itay50------ba
101 0 $aeng
102   $aUS
105   $ay-------001yy
200 1 $aFundamentals of landscaping and site planning$fJames Root
210   $aWestport$cAVI Publishing Company$d1985
215   $aIX, 158 p.$cill.$d28 cm
610 0 $aArchitettura del paesaggio
676   $a635.9
700  1$aRoot,$bJames$034573
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a990000682400403321
952   $a01 A1 III 5$b01391$fDINST
959   $aDINST
996   $aFundamentals of landscaping and site planning$9325521
997   $aUNINA

LEADER 01009nam0-2200349---450-
001 990008335920403321
005 20160523152959.0
010   $a0-521-30752-X
035   $a000833592
035   $aFED01000833592
035   $a(Aleph)000833592FED01
035   $a000833592
100   $a20060530d1985----km-y0itay50------ba
101 0 $aeng
102   $aGB
105   $a--------001yy
200 1 $aSelected papers$estudies in greek and roman history and historiography$fFrank W. Walbank
210   $aCambridge [etc.]$cCambridge University press$d1985
215   $a371 p.$d22 cm
610 0 $aAntichitą classiche$aStoriografia
676   $a340.5
676   $a938
700  1$aWalbank,$bFrank William$f<1909- >$0140223
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a990008335920403321
952   $aDDr-Scr. Walbank$b60$fDDR
952   $a938 WAL 2$bIst.f.m.4006$fFLFBC
952   $a938 WAL 2BIS$bDip.d.s.742$fFLFBC
959   $aDDR
959   $aFLFBC
997   $aUNINA

LEADER 01708nam  2200421 a 450 
001 9910695346103321
005 20061012153533.0
035   $a(CKB)5470000002369290
035   $a(OCoLC)72707052
035   $a(EXLCZ)995470000002369290
100   $a20061012d2006      ua             0
101 0 $aeng
135   $aurmn|---|||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aMedicare Part B drugs$b[electronic resource] $eCMS data source for setting payments is practical but concerns remain : testimony before the Subcommittee on Health, Committee on Ways and Means, House of Representatives /$fstatement of A. Bruce Steinwald
210  1$a[Washington, D.C.] :$cU.S. Government Accountability Office,$d[2006]
215   $a9 pages $cdigital, PDF file
225 1 $aTestimony ;$vGAO-06-971 T
300   $aTitle from title screen (viewed on Oct. 11, 2006).
300   $a"For release ... July 13, 2006."
300   $aPaper version available from: U.S. Government Accountability Office, 441 G St., NW, Rm. LM, Washington, D.C. 20548.
320   $aIncludes bibliographical references.
517   $aMedicare Part B drugs 
606   $aMedicare$xEconomic aspects
606   $aDrugs$xPrices$zUnited States
615  0$aMedicare$xEconomic aspects.
615  0$aDrugs$xPrices
700   $aSteinwald$b Bruce$01381591
712 02$aUnited States.$bCongress.$bHouse.$bCommittee on Ways and Means.$bSubcommittee on Health.
712 02$aUnited States.$bGovernment Accountability Office.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910695346103321
996   $aMedicare Part B drugs$93424343
997   $aUNINA